University of Southern California School of Pharmacy Receives First Place from AMCP Foundation in 2021 National P&T Competition

The Academy of Managed Care Pharmacy (AMCP) Foundation and its partners announced the top schools and colleges of pharmacy in its 21st Annual National Student Pharmacist P&T Competition. The competition convened student pharmacists from around the country to develop a formulary drug monograph and discuss how managed care pharmacy tools could be used to encourage adherence to evidence-based guidelines. 

AMCP Partnership Forum Provides Actionable Steps to Address Issue of Racial Health Disparities

Forum participants examined the challenges of racial health disparities, including institutional barriers to access, a lack of trust in the health care system within underserved communities, the inflexibility of benefits within an antiquated system, gaps in data acquisition and reporting, and lack of cultural competency in the health care system. After deliberating the complexities of the issues and challenging each other on authentic, real-world actions, participants suggested the some strategies as the first steps to bring about equity within health care.
Health Disparities

AMCP Statement of Support for Drs. Murthy and Levine at HHS

AMCP congratulates Dr. Vivek Murthy on his confirmation as the U.S. Surgeon General and Dr. Rachel Levine on her confirmation as Assistant Secretary of Health. Each brings a wealth of experience that will serve the American people well and help ensure more people get the health care they need. Read the full statement.

AMCP Partnership Forum Develops Innovative Strategies that Support the Use and Development of Biosimilars in the US Health Care System

Last week, more than 30 experts representing payers, pharmacists, integrated delivery systems, health economists and analysts, patient advocates, academicians, pharmaceutical manufacturers, and other key decision-makers in the managed care setting convened virtually for AMCP’s Partnership Forum “Biosimilars: Policy, Practice, and Post-Marketing Surveillance to Support Treatment and Coverage Decisions” to identify key actions that support the use and development of biosimilars in the U.S. health care system.
Biosimilars